219 related articles for article (PubMed ID: 26406400)
1. MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of long noncoding RNA ANRIL correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Cao T; Shen J; Pan W; Li C; Qiao Z
J BUON; 2018; 23(6):1862-1866. PubMed ID: 30610814
[TBL] [Abstract][Full Text] [Related]
4. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
[TBL] [Abstract][Full Text] [Related]
7. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
[TBL] [Abstract][Full Text] [Related]
8. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
9. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
12. Identification of genomic biomarkers associated with the clinicopathological parameters and prognosis of esophageal squamous cell carcinoma.
Shi ZZ; Shang L; Jiang YY; Shi F; Xu X; Wang MR; Hao JJ
Cancer Biomark; 2015; 15(6):755-61. PubMed ID: 26406417
[TBL] [Abstract][Full Text] [Related]
13. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
14. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
15. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
[TBL] [Abstract][Full Text] [Related]
16. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
Gao T; He B; Pan Y; Xu Y; Li R; Deng Q; Sun H; Wang S
Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.
Zhang BJ; Gong HY; Zheng F; Liu DJ; Liu HX
Int J Clin Exp Pathol; 2014; 7(9):6213-8. PubMed ID: 25337272
[TBL] [Abstract][Full Text] [Related]
19. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
20. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
